Clinical Trials on Rheumatoid Nodule

Total 10998 results

AB Science

Terminated

Masitinib in Refractory Active Rheumatoid Arthritis

Rheumatoid Arthritis (RA)

Czechia
Jiangsu Simcere Pharmaceutical Co., Ltd.
Bristol-Myers Squibb

Unknown

A Phase 3 Study of Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate

Rheumatoid Arthritis (RA)

China
Bristol-Myers Squibb

Completed

Methotrexate-Inadequate Response Study

Rheumatoid Arthritis (RA)

Italy, Korea, Republic of, Mexico, Taiwan, United States, Chile, France, Poland, United Kingdom, Argentina, Belgium, Ireland, Germany, Netherlands, Canada, India, Russian Federation, Turkey, Australia, South Africa, Brazil, Hungary, Per... and more
Bristol-Myers Squibb

Completed

Phase IIIB Subcutaneous Abatacept Monotherapy Study

Rheumatoid Arthritis (RA)

United States, Australia, Mexico, South Africa
Antares Pharma Inc.

Completed

Comparison of Methotrexate (MTX) and the VIBEX™ MTX Device

Rheumatoid Arthritis (RA)

United States
Astellas Pharma Inc

Recruiting

Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis

Rheumatoid Arthritis (RA)

Japan
Chinese University of Hong Kong

Completed

Early RA Vascular Randomised Controlled Study

Early Rheumatoid Arthritis

China
AbbVie

Terminated

Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)

Rheumatoid Arthritis (RA)

United States, Australia, Canada, Czechia, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Poland, Puerto Rico, Russian Federation, Slovakia, Spain, Taiwan, Turkey, Ukraine
AbbVie

Completed

A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs

Rheumatoid Arthritis (RA)

United States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Czechia, Germany, Greece, Hungary, Ireland, Israel, Italy, Korea, Republic of, Latvia, Mexico, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Romania, Russian... and more
AbbVie

Terminated

A Study in Rheumatoid Arthritis Patients Who Have Completed a Preceding Study With ABBV-105 Given Alone or in Combination With Upadacitinib

Rheumatoid Arthritis (RA)

Belgium, Canada, Czechia, Hungary, Poland, Spain, United Kingdom
Astellas Pharma Korea, Inc.

Completed

A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)

Rheumatoid Arthritis (RA)

Korea, Republic of
AbbVie

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)

Rheumatoid Arthritis (RA)

United States, Germany, Hungary, Israel, Netherlands, Poland, Puerto Rico
Federal University of São Paulo

Completed

Power Doppler in Hand Joints of Early RA Patients

Early Rheumatoid Arthritis
Cinnagen

Completed

Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RA

Active Rheumatoid Arthritis

Iran, Islamic Republic of
Astellas Pharma Global Development, Inc.

Completed

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP5094 Following Multiple Intravenous Doses in Subjects With Rheumatoid Arthritis on Methotrexate

Rheumatoid Arthritis (RA)

United States, Poland
Tigenix S.A.U.

Completed

Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients

Rheumatoid Arthritis Aggravated

Spain
Merck Sharp & Dohme LLC

Terminated

Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Despite MTX Therapy (P08683, MK-8457-008)

Rheumatoid Arthritis (RA)
University Hospital, Clermont-Ferrand
Centre de Recherche en Nutrition Humaine d'Auvergne

Unknown

Evolution of Total Energy Expenditure and Its Various Components in Active Rheumatoid Arthritis (RA)Treated With Anti-TNF Agents and Comparison With Healthy Subjects

Active Rheumatoid Arthritis

France
Guang'anmen Hospital of China Academy of Chinese...

Completed

Topical Compound Tripterygium Wilfordii Hook F for Patients With Active Rheumatoid Arthritis

Active Rheumatoid Arthritis
Kaiser Franz Josef Hospital
Landsteiner Institut

Completed

Workability in Patients With Seropositive Rheumatoid Arthritis

Seropositive Rheumatoid Arthritis
Pfizer

Terminated

Formation of Antibodies and Subsequent Prediction of Clinical Response in Patients With Rheumatoid Arthritis Treated With Four TNF Blocking Agents

Rheumatoid Arthritis (RA)

Denmark
Hutchison Medipharma Limited

Completed

A Study of the Safety, Tolerability and Pharmacokinetics of HMPL-523

Rheumatoid Arthritis (RA)

Australia
Bristol-Myers Squibb

Completed

PoC in Rheumatoid Arthritis With Methotrexate

Rheumatoid Arthritis, NOS

Taiwan, France, United States, Spain, Argentina, Mexico, Czech Republic, Korea, Republic of
Zhang, Xiao, M.D.
Xijing Hospital; Tianjin Medical University General Hospital; Central South University

Unknown

Infliximab and Classic DMARDs in the Rheumatoid Arthritis Patients (INNOVATION)

Rheumatoid Arthritis（RA）

China
AbbVie (prior sponsor, Abbott)

Completed

Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis (PREMIER)

Early Rheumatoid Arthritis

United States, Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Slovakia, Spain, Sweden, Switzerland, United Kingdom
Osservatorio Epidemiologico GISEA

Unknown

Evaluation Effects of Treatment With IL-6R Inhibitor on Clinical Response and Biomarkers in Patients With Rheumatoid Arthritis (RA) Not Responding to DMARDs and/or a First Biological Agent.

Rheumatoid Arthritis (RA)

Italy
Ablynx

Completed

Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid Arthritis

Active Rheumatoid Arthritis

United States, Russian Federation, South Africa, Canada, Serbia, Switzerland, Hungary, Belgium, Germany
Bristol-Myers Squibb

Completed

Methotrexate - Inadequate Response Device Sub-Study (MTX-IR)

Rheumatoid Arthritis (RA)
Nuon Therapeutics, Inc.

Completed

Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA)

Active Rheumatoid Arthritis

United Kingdom, United States, Argentina, Bulgaria, Serbia, Germany, Mexico, Czech Republic
Umm Al-Qura University

Recruiting

"Comparative Effect of Different Drugs Used to Tr€at Patients in Rheumatoid Arthritis Saudi Database (RASD)"

Rheumatoid Arthritis RA
SinoMab BioScience Ltd

Recruiting

A Study Assessing the Efficacy and Safety of SM03 in Patients With Active Rheumatoid Arthritis Receiving MTX

Rheumatoid Arthritis(RA)

China
National Institute of Medical Sciences and Nutrition...

Recruiting

INCMNSZ - Rheumatoid Arthritis Cohort (IRAC)

Rheumatoid Arthritis | Early Rheumatoid Arthritis

Mexico
Veena Ranganath, MD, MS

Recruiting

Use of Acthar in Rheumatoid Arthritis (RA) Related Flares

Rheumatoid Arthritis (RA)

United States
Astellas Pharma China, Inc.

Completed

A Study to Assess Safety and Efficacy of ASP015K in Participants With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to Methotrexate (MTX)

Rheumatoid Arthritis (RA)

China, Korea, Republic of, Taiwan
Chinese University of Hong Kong

Completed

Early RA MRI Early Intensive Treatment Study

Early Rheumatoid Arthritis

China
AbbVie

Active, not recruiting

A Study of Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Adult Participants With Moderate to Severe Rheumatoid Arthritis (UPHOLD)

Rheumatoid Arthritis (RA)

Argentina, Australia, Austria, Belgium, France, Germany, Greece, Ireland, Israel, Italy, Kuwait, Mexico, Russian Federation, Saudi Arabia, Spain, Switzerland, Taiwan, United Arab Emirates, Uruguay
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Study of Human Substance Balance and Biotransformation of [14C]SHR0302

Rheumatoid Arthritis (RA)

China
Sun Pharmaceutical Industries Limited

Terminated

To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis

Active Rheumatoid Arthritis

Belgium, Netherlands
Faiq Gorial

Completed

Niclosamide With Etanercept in Rheumatoid Arthritis

Rheumatoid Arthritis (RA)

Iraq
Zhejiang Hisun Pharmaceutical Co. Ltd.

Unknown

Trial of Ginsenoside Compound K (GCK) Tablet in Patients With Rheumatoid Arthritis

Early Rheumatoid Arthritis

China
Jiangsu Simcere Pharmaceutical Co., Ltd.
Bristol-Myers Squibb

Unknown

Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously

Rheumatoid Arthritis (RA)
Astellas Pharma Inc
UCB Japan Co. Ltd.

Completed

Long-term Treatment Study of CDP870 Self-injection in Patients With Active Rheumatoid Arthritis Who Are Participating in the Long-term Treatment Studies (Study 275-08-002 or Study 275-08-004) of CDP870

Active Rheumatoid Arthritis

Japan
medac GmbH
PPD

Completed

Evaluation of Patient Performance Using the Metoject Device for Subcutaneous Injection in Rheumatoid Arthritis (RA)Patient

Rheumatoid Arthritis (RA)

United States
Pfizer

Completed

Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis

Active Rheumatoid Arthritis | Arthritis, Rheumatoid | Rheumatoid Arthritis

Italy, Spain, Switzerland, France, Germany, Poland, Netherlands, United Kingdom, Monaco, Romania, Ireland, Qatar, Russian Federation
Antares Pharma Inc.

Completed

Actual Human Use of Methotrexate (MTX) Subcutaneously Administered Via the VIBEX™ MTX Auto-Injector Device

Rheumatoid Arthritis (RA)

United States
Pfizer
Emergent Product Development Seattle LLC

Completed

Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis

Active Rheumatoid Arthritis

United States, Canada, Serbia, Japan, Spain, Poland, Hungary, Argentina, Chile, Mexico
AbbVie (prior sponsor, Abbott)

Completed

Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA) (CONCERTO)

Early Rheumatoid Arthritis

United States, Argentina, Austria, Belgium, Canada, Czech Republic, Germany, Poland, Puerto Rico, Spain
Chugai Pharma Taiwan

Completed

Study of Tocilizumab in Combination With Methotrexate for Treatment of Moderate to Severe Rheumatoid Arthritis Patients

Rheumatoid Arthritis (RA)

Taiwan
Lawson Health Research Institute
Abbott

Completed

Optimization of Treatment With Adalimumab (Humira)

Rheumatoid Arthritis (RA)

Canada
Dainippon Sumitomo Pharma Europe LTd.

Terminated

Assessment of Safety, Pharmacokinetics and Efficacy in a Combination Treatment With SMP-114

Rheumatoid Arthritis (RA)

Czech Republic, Germany, Poland, United Kingdom, Hungary, Netherlands

Clinical Trials on Rheumatoid Nodule

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations